- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/06 - 1,2,3-ThiadiazolesHydrogenated 1,2,3-thiadiazoles
Patent holdings for IPC class C07D 285/06
Total number of patents in this class: 111
10-year publication summary
|
5
|
8
|
5
|
9
|
2
|
5
|
3
|
3
|
5
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corteva Agriscience LLC | 2636 |
10 |
| Bristol-myers Squibb Company | 4814 |
6 |
| Blade Therapeutics, Inc. | 15 |
5 |
| Bayer Cropscience AG | 1897 |
4 |
| Abbvie Inc. | 1841 |
4 |
| Takeda Pharmaceutical Company Limited | 2720 |
4 |
| Calico Life Sciences LLC | 104 |
4 |
| Syngenta Participations AG | 1595 |
3 |
| Dow AgroSciences LLC | 1202 |
3 |
| Roche Palo Alto LLC | 66 |
3 |
| F. Hoffmann-La Roche AG | 7832 |
2 |
| Biotechnologijos Institutas | 5 |
2 |
| Epizyme, Inc. | 359 |
2 |
| Incyte Corporation | 1046 |
2 |
| Ligand Pharmaceuticals Incorporated | 170 |
2 |
| Ustav Experimentalni Botaniky AV CR, V.v.i. | 11 |
2 |
| Sanofi | 4195 |
2 |
| Genentech, Inc. | 4052 |
1 |
| Merck Patent GmbH | 5716 |
1 |
| Abbott Laboratories | 2309 |
1 |
| Other owners | 48 |